Approximately 72 million surgeries are performed in the US every year, 1 with over 20 million involving major inpatient procedures.
POI. Strategies incorporating numerous preventive-therapeutic
approaches have been devised to manage surgical patients in a perioperative 'fast-track' manner. This article will provide a comprehensive overview of currently employed strategies and discuss the strength of evidence supporting each of these approaches.
Post-operative Ileus-Definition, Mechanism, and Risk Factors
POI is considered an iatrogenic condition and is defined as transient impairment of bowel motility following major surgery, particularly abdominal surgery. 9, [12] [13] [14] [15] Gastrointestinal (GI) motility normally resumes within two to three post-operative days, and POI should be suspected when it does not. [16] [17] [18] [19] [20] Nevertheless, it may be difficult to diagnose POI and distinguish it from a mechanical bowel obstruction even with the aid of radiology. Clinically, POI is characterized by abdominal distension, lack of flatus, and bowel sounds/motions, 12 and symptoms include nausea, vomiting, and abdominal cramps. 16 The underlying pathology of POI is best described as a lack of co-ordinated bowel motility that affects all segments of the GI tract. 16, 18 Small bowel motility usually recovers within hours of surgery, 16, 18, 19 gastric motility typically recovers within 24-48 hours post-operatively, 9, 21 and recovery of colonic motility, which is generally the limiting factor in resolving POI, usually occurs 48-72 hours post-operatively. [16] [17] [18] [19] [20] 22 Development of POI is multifactorial. These factors include disorganized GI myoelectrical activity, inhibitory sympathetic input, release of hormones, neurotransmitters, and pro-inflammatory mediators, elevated intravascular volume, and adverse effects of analgesics, particularly opioids (see Figure 1 ). Bauer and Boeckxstaens and Luckey et al. have hypothesized that intestinal inflammation in response to bowel manipulation results in activation of primary afferent neurons, which trigger inhibitory neuronal pathways leading to post-operative gut dysmotility. 13, 16 This suggests that interactions between the above-mentioned factors are responsible for POI.
Several studies have attempted to predict the risk factors for POI. A logistical regression analysis of 666 patients with non-ruptured abdominal aortic aneurysms showed POI to be associated with deterioration of cardiovascular-pulmonary-renal function. 23 While most studies have demonstrated a strong correlation between the incidence and duration of POI and opioid use, some suggest additional contributory factors including operative time, blood loss, and experience/specialization of the surgeon. 24, 25 Mechanical trauma of the GI tissue and release of pro-inflammatory mediators are implicated in the development of POI. 13 It may be reasonably expected that minimally invasive procedures would be associated with reduced risk for POI; 24 however, a review by Holte et al. found a significant association between laparoscopy and reduced POI in just two of four studies. 26 Although POI most often complicates abdominal surgery, it is also encountered following cardiothoracic, neurosurgical, and orthopaedic procedures. Disorganized GI electrical activity 19, 35 • Irregular gastric spike and slow-wave activity (stomach) 16 • Shortened and/or retrograde MMC (small bowel) 16, 18, 19 Pro-inflammatory mediators and cytokines 13, 35, [106] [107] [108] [109] • Activated macrophages release:
• Nitric oxide • O 2 free radicals • Prostaglandin • Weakens GI myoelectrical activity Opioid analgesia 26 • Inhibition of gastric motility 16 • Increased tone in antrum and duodenum 16 shown to significantly reduce POI in bowel resection patients. 41 Patients were given alvimopan 6 or 12mg or placebo at least two hours preoperatively and twice daily for up to seven days post-operatively.
Alvimopan 6 or 12mg accelerated GI recovery by 12-18 hours over placebo (hazard ratio 1.28 and 1.38, respectively; p<0.001) and time to discharge by 16 hours for 6mg and 18 hours for 12mg (p<0.001) from a mean of 147 hours for placebo. In addition, alvimopan-treated patients had reduced incidences of prolonged LOS or re-admission (p<0.001).
However, alvimopan is only approved for up to 15 doses as long-term treatment increases the risk for myocardial infarction within the first four months of therapy for patients treated with chronic opioids.
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A separate study with methylnaltrexone 0.3mg/kg administered as a 20-minute IV infusion every six hours for up to seven days was randomized among 65 colectomy patients. 39 Methylnaltrexonetreated patients experienced faster recovery of bowel function than placebo patients and the mean differences in most recovery parameters were greater than one day. No differences in opioid use, mean pain scores, or adverse events were observed between the two groups. Currently, methylnaltrexone is US Food and Drug Administration (FDA)-approved for the treatment of opioid-induced constipation only.
Intravenous Patient-controlled Analgesia
IV patient-controlled analgesia (IV-PCA) continues to be the most regularly used mode of analgesia delivery for post-operative pain control. 43 IV-PCA requires a programmable infusion pump that can deliver a pre-programmed dose of IV opioid on demand by the patient. IV-PCA drug delivery hinges on an important point: the ability of the patient to be actively engaged in his or her own pain therapy. In theory, IV-PCA is based on the principle that small patient-controlled incremental doses of an opioid will result in effective pain relief without the unwanted side effects of over-sedation and respiratory depression. The result is pain relief via a minimum effective analgesia concentration (MEAC). 44 In order for IV-PCA to be efficacious, two prerequisites must be established: individualize dosage and titrate to pain relief response to achieve MEAC and establish analgesia, and maintain constant plasma opioid concentrations to avoid peaks and troughs. Numerous algorithms for IV-PCA therapy have been established and are usually institution-specific. 45 Epidural Delivery of Analgesia/Anesthesia 55 Additionally, the risk for epidural abscess or hematoma related to epidural catheterization, though low, is real, with an incidence of abscess formation of less than 0.1% and hematoma of less than 0.05%. [56] [57] [58] [59] Once an abscess or hematoma causing neurological deficit is identified, the event becomes a neurosurgical emergency.
The risk for developing a hematoma is substantially greater when Table 1 ). 61 The 
NSAIDs = non-steroidal anti-inflammatory drugs; SC = subcutaneous; IV = intravenous; LMWH = low-molecular-weight heparin; INR = international normalized ratio.
U patients showed that these agents have opioid-sparing effects and reduce ileus after colorectal resection. 84 In these patients, first bowel sounds and motions appeared at medians of 12 and 72 hours versus 24 and 84 hours, respectively, in comparison with controls (p<0.05).
Tolerance of solid diet and hospital discharge occurred at a median of 60 hours and four days in the experimental group versus 72 hours and six days in the control group (p<0.05 and p<0.01, respectively). It must be noted that both rofecoxib and valdecoxib have been withdrawn from the market due to their adverse cardiovascular effects.
Minimally Invasive Surgery
Laparoscopy results in reduced production of endogenous opioids and cytokines compared with open surgery. 
Early Ambulation
It is a long-held belief that ambulation increases GI motility, consequently reducing POI. Waldhausen and Schirmer evaluated the effects of early ambulation on post-laparotomy patients via intraoperatively placed seromuscular bipolar electrodes on the stomach, jejunum, and colon. 93 Electrical recordings indicated no independent benefit of early ambulation on recovery of GI motility. Nevertheless, early ambulation is vital in other ways, and is a major component of multimodal fast-track peri-operative care models. 
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